文献速递脊柱关节炎其他结缔组织病

轴性银屑病关节炎与伴银屑病的轴性脊柱关节炎患者的比较:德国RABBIT-SpA登记研究分析

Comparison of patients with axial PsA and patients with axSpA and concomitant psoriasis: an analysis of the German register RABBIT-SpA.
PubMed 文献 · RMD Open · 2023-01-01

RABBIT-SpA前瞻性纵向队列研究比较了轴性银屑病关节炎(axPsA)与伴银屑病的轴性脊柱关节炎(axSpA+pso)的人口学和疾病特征。1428例axSpA中181例(13%)有银屑病记录,1395例PsA中359例(26%)有轴性受累;axPsA患者年龄更大、女性更多、HLA-B27+更少,外周表现更常见,而葡萄膜炎和炎症性肠病在axSpA+pso中更常见。疾病负担两组相似,支持axSpA与伴轴性受累的PsA为不同实体的假说。

要点

  • axPsA与axSpA+pso的临床表现不同,无论axPsA采用临床定义还是影像学定义。
  • axPsA患者年龄更大、女性更多、HLA-B27+更少,外周表现更常见。
  • 葡萄膜炎和炎症性肠病在axSpA+pso中更常见,疾病负担两组相似。

核心结论

  • axPsA与axSpA+pso的临床表现不同,无论axPsA采用临床定义还是影像学定义。
  • 这些发现支持axSpA与伴轴性受累的PsA为不同实体的假说,从axSpA随机对照试验外推治疗数据应谨慎。

研究设计与样本

  • RABBIT-SpA为前瞻性纵向队列研究。
  • axPsA定义基于风湿科医生临床判断和/或影像学(放射学骶髂关节炎符合改良纽约标准,或MRI活动性炎症征象,或放射学韧带骨赘/强直,或脊柱MRI活动性炎症征象)。
  • axSpA分层为伴银屑病(axSpA+pso)和不伴银屑病。

主要发现

  • 1428例axSpA中181例(13%)有银屑病记录。
  • 1395例PsA中359例(26%)有轴性受累,297例(21%)符合临床定义,196例(14%)符合影像学定义。
  • axPsA患者较axSpA+pso年龄更大、女性更多、HLA-B27+更少。
  • 外周表现在axPsA中较axSpA+pso更常见,而葡萄膜炎和炎症性肠病在axSpA+pso中更常见。
  • axPsA与axSpA+pso患者疾病负担(患者总体评估、疼痛、医生总体评估)相似。

临床怎么用

  • 作者认为axSpA与伴轴性受累的PsA为不同实体,从axSpA随机对照试验外推治疗数据应谨慎。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Psoriatic arthritis (PsA) and axial spondyloarthritis (axSpA) show certain overlaps: A subset of patients with PsA can develop axial involvement (axial PsA, axPsA), while a subset of patients with axSpA presents with psoriasis (axSpA+pso). Treatment strategy for axPsA is mostly based on axSpA evidence. OBJECTIVES: To compare demographic and disease-specific parameters of axPsA and axSpA+pso. METHODS: RABBIT-SpA is a prospective longitudinal cohort study. AxPsA was defined based on (1) clinical judgement by rheumatologists; (2) imaging (sacroiliitis according to modified New York criteria in radiographs or signs of active inflammation in MRI or syndesmophytes/ankylosis in radiographs or signs of active inflammation in spine MRI). axSpA was stratified into axSpA+pso and axSpA without pso. RESULTS: Psoriasis was documented in 181/1428 axSpA patients (13%). Of 1395 PsA patients, 359 (26%) showed axial involvement. 297 patients (21%) fulfilled the clinical definition and 196 (14%) the imaging definition of axial manifestation of PsA. AxSpA+pso differed from axPsA regardless whether clinical or imaging definition was used. axPsA patients were older, more often female and less often HLA-B27+. Peripheral manifestations were more often present in axPsA than in axSpA+pso, whereas uveitis and inflammatory bowel disease were more common in axSpA+pso. Burden of disease (patient global, pain, physician global) was similar among axPsA and axSpA+pso patients. CONCLUSIONS: AxPsA differs from axSpA+pso in its clinical manifestations, irrespective of whether axPsA is defined clinically or by imaging. These findings support the hypothesis that axSpA and PsA with axial involvement are distinct entities, so extrapolation of treatment data from randomised controlled trials in axSpA should be performed with caution.

来源:RMD Open,查看原文。版权归原作者所有。

引用

  1. Regierer AC, Weiß A, Proft F, et al. Comparison of patients with axial PsA and patients with axSpA and concomitant psoriasis: an analysis of the German register RABBIT-SpA. RMD Open. 2023. PMID: 36898762. doi:10.1136/rmdopen-2022-002837

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。